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INTRODUCTION
• A diagnostic transthoracic echocardiogram (TTE) is frequently employed in 
geriatric orthopaedic trauma to assess for cardiac disease which could affect 
anesthetic or operative decisions. Getting a TTE often delays care can be costly 
for patients. The purpose of the study was to determine the incidence 
proportion of new abnormal TTE findings with the potential to change 
anesthetic or surgical management in geriatric orthopaedic trauma patients 
based on their perioperative cardiac risk.
METHODS
• A retrospective study was performed at a single Level 1 trauma center following 
approval by the Institutional Review Board. Through a prospectively collected 
trauma registry, patient medical records were reviewed for all patients ages 65 
years or older who were admitted from October 2012 through October 2016 for 
extremity fractures and received TTE imaging prior to orthopaedic surgery. After 
excluding 12 patients who did not have available TTE reports in either of the two 
electronic medical records used at the site, 368 patients were included in the 
final analysis. The primary outcome was the incidence proportion of new 
abnormal TTE findings with the potential to change anesthetic or surgical 
management based on the patients perioperative cardiac risk and was defined 
as new reduced ejection fraction (EF≤30%), new pulmonary hypertension (≥60 
mm Hg), or new severe valvular disease such as aortic regurgitation, aortic 
stenosis, mitral regurgitation, mitral stenosis, pulmonic regurgitation, or 
tricuspid regurgitation6, 7. Fellowship trained cardiologists interpreted the TTE. 
Patients with audible heart murmurs upon auscultation or documented histories 
of said TTE findings were not considered. The senior anesthesia author 
individually reviewed the cases while being blinded to the adherence towards 
the clinical practice guidelines. The secondary outcomes were the overall 
proportion of cardiology consults which led to interventions based on the TTE 
results, the overall proportion of major adverse cardiac events (MACE), the risk 
of MACE in patients with a high, intermediate, or low perioperative cardiac risk. 
The cardiology team was consulted if patients had active cardiac conditions 
upon admission or if the TTE results indicate a reduced ejection fraction 
(EF≤30%) or segmental wall motion problems (hypokinesis or hyperkinesis of the 
left ventricle). The intervention was defined as an emergent change of operative 
plan or new procedure which the patient would not have otherwise received. 
MACE was defined as perioperative death, myocardial infarction, new 
arrhythmia, new heart failure, or postoperative cardiogenic shock.
DISCUSSION
• As only 7.6% of patients (9.5% in hip fracture surgery versus 7.0% in other 
fracture surgery) were discovered to have previously undiagnosed TTE results 
with the potential to change anesthetic or surgical management, the paper 
establishes a statistic different from the historical literature. Our approach 
examined de novo or unique instances of TTE showing unknown pathologies, all 
of which appeared to occur in patients irrespective of perioperative cardiac risk. 
Previous research investigated the topic from the perspective of clinical practice 
guidelines. The most concerning novel abnormalities were the 6 cases of 
reduced ejection fraction and the 3 cases of severe aortic stenosis but these 
were not mutually exclusive, however. 1.6% (n=6) of patients thus suffered from 
intraoperatively life-threatening conditions which otherwise would not have 
been acknowledged without a preoperative TTE to identify them. Cardiology 
consults were uncommonly helpful in changing management, however, the 2 
scenarios mentioned required direct emergent intervention and otherwise 
would not have been treated. Though most of the cardiology consults were 
made in response to active cardiac conditions and not the TTE results 
themselves, we did not look at changes in perioperative medication regulation 
because they still did not modify anesthetic or surgical management and often 
delayed treatment. In one case, a patient had open wounds from a mangled 
extremity left untreated for many days during the wait for a cardiology consult, 
which may have caused the limb to become unsalvageable and subsequently 
amputated. Several other cardiology consults recommended diagnostic workups 
yielding no actual intervention, again delaying treatment, or simply 
recommended perioperative fluid balance, something which would have been 
done despite the cardiology consult. Regarding MACE in the 16.8% of patients 
(22.5% in hip fracture surgery versus 15.8% in other fracture surgery), there was 
a clinically significant but statistically insignificant association with perioperative 
cardiac risk, implying the indication level for TTE ambiguously tell us how 
patients will do in the future, suggesting our low risk group in particular may 
have been underpowered. The TTE infrequently reveals even theoretically 
actionable information. While increases in time to surgery has been linked with 
mortality in geriatric hip fracture patients, the rare potential benefit of these 
consults and tests must be weighed against the delays and expenses they incur. 
Routine TTE in all geriatric orthopedic trauma patients did not appear to change 
management in our cohort. Ultimately, further guidelines and studies are likely 
warranted to understand the most pragmatic situations for TTE.
• Table 1: Demographics; Table 2: New Abnormal TTE Findings Stratified by 
Perioperative Cardiac Risk
RESULTS
• Overall, 8% of the new abnormal TTE findings had the potential to change anesthetic or 
surgical management (n=28, 95% confidence interval [CI], 5 to 11%). There were no 
significant differences in the proportion of new abnormal TTE findings between those 
with a high, intermediate, or low perioperative cardiac risk (P=0.50). The TTE results led 
to cardiology consults which yielded interventions in 2 patients (95% CI, 0.6 to 7.6%). 
17% of the sample suffered a major adverse cardiac event (MACE) (n=62, 95% CI, 13 to 
21%). The proportion of patients with major adverse cardiac events did not differ based 
on the patient’s perioperative cardiac risk (P=0.46).
 High 
Perioperative 
Cardiac Risk 
(n=170) 
Intermediate 
Perioperative 
Cardiac Risk 
(n=165) 
Low 
Perioperative 
Cardiac Risk 
(n=33) 
Total 
(n=368) 
P 
Value 
 High versus 
Intermediate 
RR (95% 
CI) 
High 
versus 
Low 
RR 
(95% 
CI) 
Intermediate 
versus Low 
RR (95% 
CI) 
New Abnormal TTE 
Findings Proportion (n) 
8.8 (15) 7.3 (12)  3.0 (1) 7.6 (28) 0.50  1.21 (-0.04 
to 0.07) 
2.93 
(-0.01 
to 
0.13) 
2.43 (-0.03 
to 0.11) 
 
  All 
(n=368) 
High 
Perioperative 
Cardiac Risk 
(n=170) 
Intermediate 
Perioperative 
Cardiac Risk 
(n=165) 
Low 
Perioperative 
Cardiac Risk 
(n=33) 
P 
Value 
Age, years, 
mean (SD) 
 80 (9) 81 (9) 80 (9) 77 (9) 0.04 
Sex, female, n 
(%) 
 268 (73) 119 (70) 126 (76) 23 (70) 0.39 
Race, n (%)       
 White 313 (85) 146 (86) 141 (85) 26 (79) 0.63 
 African-American 34 (9) 17 (10) 13 (8) 4 (12)  
 Other 21 (6) 7 (4) 11 (7) 3 (9)  
ASA, n (%)       
 Class I 3 (1) 0 (0) 2 (1) 1 (3) 0.01 
 Class II 34 (9) 8 (5) 22 (13) 4 (12)  
 Class III 260 (71) 121 (71) 113 (68) 26 (79)  
 Class IV 71 (19) 41 (24) 28 (17) 2 (6)  
Injury severity 
score, mean 
(SD) 
 9 (2) 9 (2) 9 (2) 8 (3) 0.08 
Comorbidities, 
n (%) 
      
 Hypertension 269 (73) 129 (76) 118 (72) 22 (67) 0.46 
 Diabetes 40 (11) 13 (8) 21 (13) 6 (18) 0.12 
 Coronary heart disease 80 (22) 46 (27) 29 (18) 5 (15) 0.07 
 Hypothyroidism 46 (13) 21 (12) 24 (15) 1 (3) 0.19 
 COPD 51 (14) 21 (12) 26 (16) 4 (12) 0.64 
Fracture 
location, n (%) 
      
 Hip  84 (23) 44 (26) 36 (22) 8 (12) 0.62 
 Upper extremity 49 (13) 22 (13) 21 (13) 6 (18)  
 Pelvis/acetabulum 48 (13) 22 (13) 23 (14) 3 (9)  
 Other lower extremity 
fracture surgery 
187 (51) 82 (48) 85 (52) 20 (61)  
 
